Alembic Pharma Q3 Results | Net profit declines 23% to ₹138 crore, net sales up 4%

Share it

Shares of Alembic Pharmaceuticals Ltd ended at ₹924.20, down by ₹12.90 or 1.38% on the BSE.

Leave a Comment

Your email address will not be published. Required fields are marked *